You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AKTX Exercise Disclosure
Patel Samir Rashmikant · SEC Form 4 · Filed Jul 17, 2026
Exercise
Calculated transaction value
$249.93K
Patel Samir Rashmikant Director / Ten Percent Owner
AKTX
Transaction date
Jul 7, 2026
Public filing date
Jul 17, 2026
Filing lag
Filed 10 days later
AKTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Pre-Funded Warrant to purchase ADSs on American Depositary Shares representing Ordinary Shares
- Quantity / price
- 15,466 shares @ $16.16
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-033634
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$392.01K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Akari Therapeutics Plc AKTX | Exercise | Jul 7, 2026 | $9.67K |
| Akari Therapeutics Plc AKTX | Exercise | Jul 7, 2026 | $6.19 |
| Akari Therapeutics Plc AKTX | Exercise | Jul 7, 2026 | $2.32 |
| Akari Therapeutics Plc AKTX | Exercise | Jul 7, 2026 | $38.69K |
| Akari Therapeutics Plc AKTX Current | Exercise | Jul 7, 2026 | $249.93K |
| Akari Therapeutics Plc AKTX | Exercise | Jul 7, 2026 | $93.71K |